EXOSC5 and gastric cancer: Kaplan-Meier analysis revealed that GC patients with overexpression EXOSC5 had remarkably shorter overall survival (OS) compared to patients with low EXOSC5 expression in K-M plotter and our cohorts (Figure 1G).